You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Claims for Patent: 11,197,849

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,197,849

Title:	Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
Abstract:	Provided is a pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.0003 to 0.01% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof.
Inventor(s):	Naveed Shams, Henk-Andre Kroon, Hisashi Kawata, Noriko Kawabata
Assignee:	Santen Pharmaceutical Co Ltd
Application Number:	US16/887,108
Patent Claims:	1. A liquid pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.001 to 0.003% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl) aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof; and water. 2. A liquid pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.002% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl) aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof; and water. 3. The liquid pharmaceutical preparation according to claim 1, in which the preparation is for treatment of glaucoma. 4. The liquid pharmaceutical preparation according to claim 1, in which the preparation is for treatment of ocular hypertension. 5. The liquid pharmaceutical preparation according to claim 1, in which the preparation does not include other therapeutic agents for glaucoma. 6. The liquid pharmaceutical preparation according to claim 1, in which the preparation is not used in combination with other therapeutic agents for glaucoma. 7. An eye drop comprising the liquid pharmaceutical preparation of claim 1. 8. A method for treatment or prevention of glaucoma or ocular hypertension, comprising administrating the liquid pharmaceutical preparation of claim 1 to a patient who needs the treatment or prevention of glaucoma or ocular hypertension. 9. A method for treatment of glaucoma, comprising administrating the liquid pharmaceutical preparation of claim 3 to a patient who needs the treatment of glaucoma. 10. A method for treatment of ocular hypertension, comprising administrating the liquid pharmaceutical preparation of claim 4 to a patient who needs the treatment of ocular hypertension. 11. The method of claim 8, in which the liquid preparation does not include other therapeutic agents for glaucoma. 12. The method of claim 8, the liquid preparation is not used in combination with other therapeutic agents for glaucoma. 13. The method of claim 8, in which the administrating is instillation. 14. The method of claim 13, in which the instillation is provided once or twice a day. 15. The method of claim 8, in which a dose of one or two drops is instilled. 16. The method of claim 8, in which a dose of one drop is instilled once a day. 17. The method of claim 8, wherein the patient is a human.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.